Compare BCSF & MLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BCSF | MLAB |
|---|---|---|
| Founded | 2015 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Industrial Machinery/Components |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 838.7M | 719.9M |
| IPO Year | 2015 | 1995 |
| Metric | BCSF | MLAB |
|---|---|---|
| Price | $10.22 | $128.25 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 4 | 3 |
| Target Price | $12.63 | ★ $117.50 |
| AVG Volume (30 Days) | ★ 508.6K | 80.2K |
| Earning Date | 11-09-2026 | 11-09-2026 |
| Dividend Yield | ★ 18.79% | 0.50% |
| EPS Growth | N/A | ★ 436.11 |
| EPS | 0.27 | ★ 0.49 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $2.14 |
| Revenue Next Year | N/A | $6.45 |
| P/E Ratio | ★ $37.24 | $263.53 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $10.00 | $69.51 |
| 52 Week High | $14.70 | $144.35 |
| Indicator | BCSF | MLAB |
|---|---|---|
| Relative Strength Index (RSI) | 32.24 | 50.92 |
| Support Level | N/A | $89.77 |
| Resistance Level | $11.35 | $132.70 |
| Average True Range (ATR) | 0.26 | 5.05 |
| MACD | -0.03 | -0.69 |
| Stochastic Oscillator | 16.40 | 26.63 |
Bain Capital Specialty Finance Inc is an externally managed, closed-end, non-diversified management investment company. The company's objective is to provide risk-adjusted returns and current income to investors by investing in middle-market companies. Its portfolio of investments includes First Lien Senior Secured Loan, Preferred Equity, Equity Interest, Warrants, and Second Lien Senior Secured Loan, and others.
Mesa Laboratories Inc manufactures life sciences tools and critical quality control solutions. It operates in four divisions: i) Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. ii) Clinical Genomics division develops, manufactures, and sells sensitive, low-cost, high-throughput genetic analysis tools and related consumables. iii) The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. iv) The Calibration Solutions division develops, manufactures, sells, and services quality control products.